In our study, the mean of LAP index in the patients and the control group were respectively (38,2±42,6 and 12,0±13.1, p=0,000), TG (115,9±67,9 mg/ dl and 82,8±46,3 mg/dl, p=0,004), HOMA-IR (3,5±2,4 and 2,2±1,3 p=0,01), total cholesterol( 178,2± 35,4 mg/ dl and 160,0±27,7 mg/dl p=0,02), insulin (6,1±10,1µU/ml and 11,0±6,3 µU /ml p=0,02), The positive correlation were detected among BMI and LAP index (r=0,73 p=0,000), HOMA-IR (r=0,48 p=0,000), fasting insulin levels ( r=0,46 p=0,000) respecttively .
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Conclusion
High LAP index may help for the evaluation of metabolic risk in women with PCOS. In our study, we also determined positive correlations LAP index and other metabolıc parameters.such as TG, LDL-C, HOMA-IR and fasting insulin levels. Increment of LAP may be associated with high cardiovascular risc.
Introduction
The polycystic ovary syndrome (PCOS) is an important cause of both menstrual irregularity and androgen excess in women.
When fully expressed (for example, in women with hirsutism, irregular menstrual cycles, obesity, and a classic ovarian morphology on transvaginal ultrasound), PCOS can be readily HOMA IR glucose was calculated with the formula of (mmol/L)x insulin(µU/ml) /22.5.
.
